YS Biopharma Co.. Ordinary Shares company info

What does YS Biopharma Co.. Ordinary Shares do?
YS Biopharma (NASDAQ:YS) focuses on the development, manufacturing, and commercialization of immunotherapy products and vaccines. The company's portfolio includes advanced biomedical products aimed at enhancing the lives of patients with various diseases. YS Biopharma is dedicated to pushing the boundaries of science to create transformative medicines. It works closely with healthcare professionals and communities to address some of the most challenging healthcare issues globally. YS Biopharma’s objective is to sustain innovation in the biopharmaceutical field while ensuring the highest standards of safety and efficacy for their therapies.
YS Biopharma Co.. Ordinary Shares company media
Company Snapshot

Is YS Biopharma Co.. Ordinary Shares a public or private company?

key
Ownership
Public

How many people does YS Biopharma Co.. Ordinary Shares employ?

people
Employees
754

What sector is YS Biopharma Co.. Ordinary Shares in?

pie chart
Sector
Healthcare

Where is the head office for YS Biopharma Co.. Ordinary Shares?

location pin
Head Office
Beijing, China

What year was YS Biopharma Co.. Ordinary Shares founded?

founded flag
Year Founded
2002
What does YS Biopharma Co.. Ordinary Shares specialise in?
/Pharmaceutical Products /Biotechnology Services /Research Development /Biopharmaceutical Manufacturing /Clinical Trials /Global Distribution

What are the products and/or services of YS Biopharma Co.. Ordinary Shares?

Overview of YS Biopharma Co.. Ordinary Shares offerings
Hepatitis vaccines, offering prevention against hepatitis virus infections.
Influenza vaccines, aimed at combating seasonal and pandemic influenza strains.
mRNA technology platform for developing next-generation vaccines and therapeutics.
Biopharmaceutical contract development and manufacturing organization (CDMO) services, catering to global clients.
Research and development in oncology, focusing on innovative cancer treatments.
Investment in biotechnology startups, fostering innovation in the biopharmaceutical industry.